Contineum Therapeutics, Inc. (CTNM)

NASDAQ: CTNM · Real-Time Price · USD

11.92

+1.06 (9.76%)

At close: Sep 26, 2025, 4:00 PM EDT

11.42

-0.50 (-4.19%)

After-hours: Sep 26, 2025, 7:33 PM EDT

Contineum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	334	378	-	-	-
Enterprise Value	165	164	-	-	-
Last Close Price	11.92	14.65	-	-	-
PB Ratio	1.80	1.91	-	-	-
P/TBV Ratio	1.95	1.91	-	-	-
Debt / Equity Ratio	0.03	0.03	0.01	0.15	0.08
Debt / EBITDA Ratio	-	-	0.03	-	-
Debt / FCF Ratio	-	-	0.03	-	-
Asset Turnover	-	-	0.55	-	-
Quick Ratio	24.33	20.53	22.83	6.26	18.78
Current Ratio	24.51	20.69	23.29	6.41	18.99
Return on Equity (ROE)	-29.24%	-26.19%	27.71%	-48.09%	-
Return on Assets (ROA)	-20.42%	-18.54%	11.10%	-23.44%	-
Return on Capital (ROIC)	-20.88%	-19.30%	11.79%	-25.44%	-
Return on Capital Employed (ROCE)	-	-	12.90%	-	-
Earnings Yield	-17.01%	-11.19%	-	-	-
FCF Yield	-14.00%	-8.83%	-	-	-
Buyback Yield / Dilution	-240.41%	-469.95%	-51.38%	-6.35%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q